standard]
MYASRIREAVDGGNMQLYVEMDPSERYGRFKDVLGKGAMKTVYRAFDELL
GVEVAWNQVKLNDVFGSPQELQRLYSEVHLLKSLNHDSIMRSRASWIDVE
RRTFNFITEMFTSGTLREYRKKYKRVNIRAIKDWARQILEGLDYLHRHDP
PVIHRDLKCDNIFVNGHLGQVKLGDLGLAAILRGTSHAHSVIGTPEFMAP
ELYEEEYDELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPE
AFYRIEDVEARRFVGRCLEKAANRPSARELLMDPFLSVEEVEELLANVAK
IPSQKAALSGKSEELLPLSVVQARSTDMSITGTLNQEDDTIFLKVHISDK
DGSARNIYFPFDIMSDTSLDVATEMVKELEITDWDPLEIADMIGEEISTL
VPSWKDSCSSLINQQHSFNYADEEDDNDDNGPHHPFYSTSSFSSSHASLP
GLFSLSDAEFYQAKALHDWHQEDTTSIDDASSISSSCSDKYSNLKYYSAN
EDSFLPISDKEEIHCIAKTPKCTRFGPEGSTTRNCNFNVVGCSSKRQQKM
VRTRSMVDIRSQLLHRTLVEEINKRRLFKTVGAVEHVGYHEVGDFSEGEK
TSGISKGKSVKECGIRGFRW
|
IPR000719; Protein kinase, catalytic domain IPR002290; Serine/threonine-protein kinase domain IPR008271; Serine/threonine-protein kinase, active site IPR017442; Serine/threonine-protein kinase-like do |